We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+11.08%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$134B
AUM Growth
+$14.8B
Cap. Flow
+$2.42B
Cap. Flow %
1.81%
Top 10 Hldgs %
25.29%
Holding
4,017
New
232
Increased
1,652
Reduced
1,816
Closed
191

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$219M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$157M
3
AMD icon
Advanced Micro Devices
AMD
+$131M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$102M
5
FANG icon
Diamondback Energy
FANG
+$90.5M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$124M
2
KEYS icon
Keysight
KEYS
+$84.3M
3
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$77.8M
4
UL icon
Unilever
UL
+$38.3M
5
ADBE icon
Adobe
ADBE
+$38M

Sector Composition

Rank Sector Weight
1 Technology 15.71%
2 Financials 9.02%
3 Healthcare 7.82%
4 Industrials 6.8%
5 Consumer Discretionary 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRRX
3776
DELISTED
DURECT Corp
DRRX
$8.67K ﹤0.01%
14,700
-6,150
-29% -$8.77K
PPBT
3777
Purple Biotech
PPBT
$2.52M
$8.58K ﹤0.01%
55
– –
SENS icon
3778
Senseonics Holdings Inc
SENS
$416M
$8.38K ﹤0.01%
735
– –
MLSS icon
3779
Milestone Scientific
MLSS
$43M
$8.28K ﹤0.01%
12,000
– –
EGLX
3780
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$8.23K ﹤0.01%
38,231
– –
LMDX
3781
DELISTED
LumiraDx Limited Common Shares
LMDX
$8.14K ﹤0.01%
129,361
+110,883
+600% +$12.9K
ADAP
3782
DELISTED
Adaptimmune Therapeutics
ADAP
$8.1K ﹤0.01%
10,218
-151
-1% -$85
AMRS
3783
CALL
DELISTED
Amyris Inc.
AMRS
$8K ﹤0.01%
1,000
– –
QTTB icon
3784
Q32 Bio
QTTB
$459M
$7.86K ﹤0.01%
718
-166
-19% -$2.43K
ACB
3785
Aurora Cannabis
ACB
$216M
$7.21K ﹤0.01%
1,514
-246
-14% -$1.19K
DCFC
3786
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$6.2K ﹤0.01%
141
-21
-13% -$995
NEE icon
3787
PUT
NextEra Energy
NEE
$179B
$5.5K ﹤0.01%
100
-26,500
-100% -$1.51M
PVLA
3788
Palvella Therapeutics
PVLA
$2.22B
$5.46K ﹤0.01%
375
– –
INO icon
3789
Inovio Pharmaceuticals
INO
$79.1M
$5.34K ﹤0.01%
873
-417
-32% -$2.06K
GOEV
3790
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$3.42K ﹤0.01%
29
– –
MDNA
3791
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$3.17K ﹤0.01%
10,400
– –
FAZE
3792
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$2.58K ﹤0.01%
14,311
– –
TCRT icon
3793
Alaunos Therapeutics
TCRT
$4.81M
$1.19K ﹤0.01%
112
-70
-38% -$843
FRBK
3794
DELISTED
Republic First Bancorp Inc
FRBK
$458 ﹤0.01%
15,250
– –
BLPH
3795
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$370 ﹤0.01%
10,000
– –
RVLP
3796
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$71 ﹤0.01%
+23,696
New +$2.35K
AMRS
3797
DELISTED
Amyris Inc.
AMRS
$36 ﹤0.01%
14,219
-608
-4% -$2
POL.WS
3798
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$15 ﹤0.01%
+10,000
New +$15
APPH
3799
DELISTED
AppHarvest, Inc. Common Stock
APPH
$12 ﹤0.01%
+11,548
New +$12
NOGNW
3800
DELISTED
Nogin, Inc. Warrant
NOGNW
$7 ﹤0.01%
14,287
– –
150 151
152
153 154

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Raymond James & Associates held 4,017 positions worth $134B, up 12% from $119B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q4 2023 filing shows 232 new, 1,652 increased, 1,816 reduced and 191 closed positions. Its largest new stake was Delek US: 515,324 shares worth $13.3M. The largest sale was Pioneer Natural Resource Co., an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2023 buy was Delek US: 515,324 shares worth $13.3M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $219M increase.
  • Raymond James & Associates's biggest Q4 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $124M.
  • Raymond James & Associates fully exited Kayne Anderson NextGen Energy & Infrastructure, Inc. in Q4 2023, selling an estimated $22.8M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $134B portfolio in Q4 2023.
  • Raymond James & Associates opened 232 new positions and closed 191 in Q4 2023.
  • Raymond James & Associates's portfolio value rose 12% quarter-over-quarter to $134B.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.